Production (Stage)
Merck KGaA
MKGAF
$129.80
-$1.65-1.26%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.56B | 5.78B | 5.79B | 5.76B | 5.56B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.56B | 5.78B | 5.79B | 5.76B | 5.56B |
| Cost of Revenue | 2.25B | 2.43B | 2.33B | 2.28B | 2.29B |
| Gross Profit | 3.31B | 3.35B | 3.46B | 3.48B | 3.27B |
| SG&A Expenses | 1.54B | 1.69B | 1.55B | 1.60B | 1.54B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 126.28M | -244.11M | 124.23M | 334.74M | 84.68M |
| Total Operating Expenses | 4.50B | 4.43B | 4.58B | 4.91B | 4.55B |
| Operating Income | 1.06B | 1.35B | 1.21B | 853.53M | 1.01B |
| Income Before Tax | 1.01B | 863.43M | 1.15B | 844.92M | 975.94M |
| Income Tax Expenses | 229.41M | 149.24M | 253.96M | 193.74M | 217.12M |
| Earnings from Continuing Operations | 776.63M | 714.20M | 892.69M | 651.18M | 758.82M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.16M | -3.20M | -3.30M | 2.15M | -5.43M |
| Net Income | 773.47M | 711.00M | 889.40M | 653.34M | 753.40M |
| EBIT | 1.06B | 1.35B | 1.21B | 853.53M | 1.01B |
| EBITDA | 1.56B | 1.74B | 1.70B | 1.33B | 1.50B |
| EPS Basic | 1.78 | 1.64 | 2.04 | 1.51 | 1.74 |
| Normalized Basic EPS | 1.44 | 2.05 | 1.64 | 1.22 | 1.39 |
| EPS Diluted | 1.78 | 1.64 | 2.04 | 1.51 | 1.74 |
| Normalized Diluted EPS | 1.44 | 2.05 | 1.64 | 1.22 | 1.39 |
| Average Basic Shares Outstanding | 434.91M | 434.80M | 434.95M | 433.57M | 433.75M |
| Average Diluted Shares Outstanding | 434.91M | 434.80M | 434.95M | 433.57M | 433.75M |
| Dividend Per Share | -- | 2.35 | -- | -- | -- |
| Payout Ratio | 6.26% | 0.00% | -- | 161.12% | 7.49% |